Section 6801. Definition of practice of pharmacy  


Latest version.
  • 1. The practice of the
      profession of pharmacy  is  defined  as  the  administering,  preparing,
      compounding,  preserving,  or  the  dispensing  of  drugs, medicines and
      therapeutic devices  on  the  basis  of  prescriptions  or  other  legal
      authority.
        2.  A  licensed  pharmacist may execute a non-patient specific regimen
      prescribed or  ordered  by  a  licensed  physician  or  certified  nurse
      practitioner,  pursuant  to  rules  and  regulations  promulgated by the
      commissioner. When  a  licensed  pharmacist  administers  an  immunizing
      agent, he or she shall:
        (a)  report  such  administration  to  the patient's attending primary
      health care practitioner or practitioners, if any, pursuant to rules and
      regulations of the commissioner;
        (b) provide information to the patient on the importance of  having  a
      primary  health  care  practitioner,  developed  by  the commissioner of
      health; and
        (c)  report  such   administration,   absent   of   any   individually
      identifiable health information, to the department of health in a manner
      required by the commissioner of health.
        3.  No pharmacist shall administer immunizing agents without receiving
      training satisfactory to the commissioner and the commissioner of health
      which shall include, but not be limited  to,  techniques  for  screening
      individuals    and    obtaining    informed   consent;   techniques   of
      administration; indications, precautions and  contraindications  in  the
      use  of agent or agents; record keeping of immunization and information;
      and handling emergencies, including anaphylaxis and needlesticks.
        4. The commissioner of health, in consultation with the  commissioner,
      shall  prepare  and submit a report to the governor and the legislature,
      on or before December thirty-first, two thousand eleven,  reporting  the
      results  and  evaluating  the  effectiveness  and  impact,  if  any,  of
      implementation of subdivision two of this section  upon  the  supply  of
      such  immunizing agents for the prevention of influenza and pneumococcal
      disease, upon the geographical distribution of such agents, and upon the
      distribution of such  agents  among  health  care  providers,  including
      physicians, and pharmacies in New York state.
        * NB Effective until March 31, 2012